Rhamnetin-induced suppression of clonal expansion during early stage of adipogenesis

Arch Pharm Res. 2012 Jun;35(6):1083-9. doi: 10.1007/s12272-012-0616-7. Epub 2012 Jun 30.

Abstract

Adipocyte differentiation plays a pivotal role in the progression of obesity which is a major risk factor for several diseases such as diabetes, hypertension and coronary heart disease. In this study, the inhibitory effect of rhamnetin, a flavonoid compound, on adipogenesis in 3T3-L1 cells was investigated. Rhamnetin decreased the accumulation of lipid droplets, and inhibited the elevation of triglyceride content in the adipocytes (IC(50) = 17.3 μM). The expressions of PPARγ, C/EBPα, and perilipin, adipocyte differentiation markers, were significantly reduced by rhamnetin. Triglyceride biosynthesis and clonal expansion of adipocytes were completely inhibited during the early stage by rhamnetin. Additionally, rhamnetin significantly decreased the expression of C/EBPβ, an early stage marker. Our results indicate that suppression of clonal expansion during the early stage of adipogenesis by rhamnetin may be associated with inhibition of the C/EBPβ, C/EBPα, and PPARγ pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / drug effects*
  • Adipocytes / metabolism
  • Adipogenesis / drug effects*
  • Animals
  • Biomarkers / metabolism
  • CCAAT-Enhancer-Binding Protein-alpha / metabolism
  • Carrier Proteins / metabolism
  • Cell Proliferation / drug effects*
  • Clone Cells
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Mice
  • Mitosis / drug effects
  • PPAR gamma / metabolism
  • Perilipin-1
  • Phosphoproteins / metabolism
  • Quercetin / analogs & derivatives*
  • Quercetin / pharmacology
  • Signal Transduction / drug effects
  • Time Factors
  • Triglycerides / metabolism

Substances

  • Biomarkers
  • CCAAT-Enhancer-Binding Protein-alpha
  • Carrier Proteins
  • PPAR gamma
  • Perilipin-1
  • Phosphoproteins
  • Triglycerides
  • rhamnetin
  • Quercetin